ALISON PERRYMAN: Open Payments
NPI 1124627690 · HERNANDO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,611 in 93 payments from 11 companies in 2025. Trend: 2023 $1,139 · 2024 $1,386 · 2025 $1,611
Food & beverage: $1,598Education: $12
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $491 |
| Collegium Pharmaceutical, Inc. | 18 | $232 |
| Neurocrine BioSciences, Inc. | 14 | $230 |
| ABBVIE INC. | 19 | $214 |
| Supernus Pharmaceuticals, Inc. | 8 | $136 |
| Axsome Therapeutics, Inc. | 4 | $102 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $84 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Lundbeck LLC | 1 | $32 |
| E.R. Squibb & Sons, L.L.C. | 1 | $28 |
Products named: CAPLYTA, Jornay PM, INGREZZA, VRAYLAR, Qelbree, Auvelity, TRINTELLIX, REXULTI.
Industry payments across MS — which companies pay providers there.
